What Is the Best Surgery for Gastroparesis?

No single surgery works best for every person with gastroparesis. The right procedure depends on which symptoms dominate, what is causing the stomach to empty slowly, and how much of the dysfunction traces back to the pylorus, the muscular valve at the stomach’s exit. That said, gastric peroral endoscopic pyloromyotomy, commonly called G-POEM, has gained the most momentum in recent years as a minimally invasive first-line surgical option, backed by growing trial data and a sham-controlled study showing clear superiority over placebo. But G-POEM is not the only game in town, and for certain patients, gastric electrical stimulation, laparoscopic pyloroplasty, or even gastric bypass may be the better fit.

When Surgery Enters the Conversation

Surgery is never the starting point for gastroparesis. The condition is first managed with dietary changes, such as smaller, more frequent meals with less solid food, along with medications like metoclopramide (a prokinetic) and antiemetics for nausea and vomiting.¹ Surgery becomes relevant only when a patient has medically refractory gastroparesis, defined as persistent symptoms despite confirmed delayed gastric emptying on a scintigraphy scan and a reasonable trial of first-line drugs.² That threshold matters because the surgical options all carry trade-offs, and no procedure is guaranteed to resolve symptoms.

The cause of the gastroparesis also shapes the surgical conversation. Diabetic gastroparesis, idiopathic gastroparesis (no identifiable cause), and postsurgical gastroparesis (triggered by a prior operation) are the three main categories. Some procedures work better for one group than another. For instance, gastric electrical stimulation has shown strong results in diabetic patients specifically, while G-POEM appears to benefit diabetic patients the most among the subgroups but still helps idiopathic cases.³

G-POEM, the Frontrunner

G-POEM is an endoscopic procedure, meaning it is performed through the mouth with no external incisions. A gastroenterologist creates a small tunnel through the stomach lining, then cuts the inner muscle fibers of the pylorus. This loosens the valve so food can pass through more easily. The procedure typically takes about an hour, and most patients go home the next day.

A 2024 systematic review and network meta-analysis covering 21 studies and nearly 1,200 patients found that G-POEM significantly reduced all symptom subscores and, uniquely among pyloric interventions, also caused a measurable improvement in how quickly the stomach actually emptied on scintigraphy.⁴ That distinction matters because some treatments make patients feel better without changing the underlying emptying delay, raising questions about whether the improvement is durable.

The strongest piece of evidence for G-POEM comes from a sham-controlled trial, where some patients received the real procedure and others underwent a fake version under anesthesia, with neither group knowing which they received. About seven in ten patients who got the real G-POEM met the threshold for treatment success, compared with roughly two in ten in the sham group.³ That gap is meaningful because gastroparesis symptoms respond heavily to placebo, and before this trial, critics could reasonably argue that G-POEM’s benefits might be partly psychological.

A large international prospective trial reported clinical success at one year of about 56%, with patients who had more severe baseline symptoms and greater gastric retention responding best.⁵ Longer-term data from a meta-analysis found that symptom scores remained significantly improved at three years out.⁶ The complication rate is generally low, and adverse events appear less frequent with G-POEM than with surgically implanted devices.

Laparoscopic Pyloroplasty

Pyloroplasty achieves something similar to G-POEM but through a traditional surgical approach. A surgeon makes small abdominal incisions and physically widens the pylorus by cutting through the full thickness of the muscle and sewing it open. It has been around longer than G-POEM and has a solid track record in centers that specialize in gastroparesis surgery.

In one series of 177 patients, about 86% showed improvement in gastric emptying after laparoscopic pyloroplasty, with the average time for the stomach to half-empty dropping from roughly three hours to an hour and a half. Symptom scores for nausea, vomiting, bloating, and early satiety all dropped significantly within three months. The complication rate was under 7%, with a leak rate around 1%.⁷ About one in ten patients eventually needed a follow-up surgical intervention, most commonly a gastric stimulator implant or a feeding tube.

A direct comparison study found that both pyloroplasty and G-POEM significantly reduced symptom scores, though a slightly higher proportion of pyloroplasty patients needed additional surgery for refractory symptoms afterward (about 13%).⁸ The network meta-analysis noted that pyloroplasty improved symptoms but, unlike G-POEM, did not produce a statistically significant change in scintigraphic gastric emptying.⁴ Whether that distinction affects long-term durability is still debated.

The practical difference for patients is often recovery and access. G-POEM requires a skilled interventional endoscopist and is available at fewer centers. Pyloroplasty can be done by a broader range of surgeons familiar with laparoscopic foregut work. Both target the same structure and both aim to relieve pyloric obstruction, so the choice often comes down to local expertise and patient preference.

Gastric Electrical Stimulation

Gastric electrical stimulation, marketed as Enterra Therapy, takes a completely different approach. Instead of opening the pylorus, a surgeon implants a small pacemaker-like device under the skin of the abdomen and threads two electrodes into the stomach wall. The device delivers high-frequency, low-energy electrical pulses continuously. It received FDA approval under a humanitarian device exemption in 2000, meaning it was approved based on a smaller evidence base than is typically required.

GES does not speed up gastric emptying. That has been confirmed repeatedly. Instead, it seems to work by altering how the brain processes signals from the stomach, raising the threshold at which stomach distension causes discomfort and affecting the balance between sympathetic and vagal nerve activity.⁹ The primary benefit is relief from nausea and vomiting specifically, with response rates reported between 50% and 70%.¹⁰

A prospective study in diabetic gastroparesis patients found that weekly vomiting frequency dropped by about 57% after six weeks and by roughly 68% at one year, with improvements in quality of life, total symptom scores, and even gastric emptying in that particular cohort.¹¹ Another study followed patients for a mean of over two years and found about 80% reported symptom improvement, with diabetic and idiopathic patients responding at similar rates.¹²

The downsides of GES are real. It requires surgical implantation and carries hardware-related risks. One large institutional study found that 58% of GES patients eventually needed an additional procedure after implantation, most commonly for nutritional access or problems with the device pocket under the skin. About 12% had the device removed entirely, mainly because symptoms persisted or hardware issues developed.¹³ That reoperation rate is worth weighing seriously, particularly when less invasive options exist.

The Sham-Controlled Evidence Problem

A persistent challenge in gastroparesis surgery research is the placebo effect. Patients with chronic nausea and vomiting who undergo any procedure, even a fake one, often report feeling better afterward. This makes it hard to know how much of a treatment’s benefit is real.

For GES, the sham evidence is underwhelming. Four studies compared having the device turned on versus secretly turned off in the same patients. The total symptom score dropped modestly when the device was active, but none of the individual symptom subscores reached statistical significance on their own.⁴ That does not mean GES is useless, but it does suggest the effect is smaller than uncontrolled before-and-after studies imply. The bulk of GES data comes from open-label studies where both patients and doctors know the device is on, inflating the apparent benefit.

G-POEM fares better on this front. Its sham-controlled trial showed a roughly threefold difference in success rates between real and fake procedures, which is a large and convincing gap.³ This is one of the main reasons G-POEM has gained favor so quickly: it has passed a test that GES has largely failed to pass convincingly.

Head-to-Head Comparison of G-POEM and GES

A propensity-matched study directly compared long-term outcomes after G-POEM versus GES implantation. Over a median follow-up of about 28 months, G-POEM produced a significantly better and longer-lasting clinical response. The estimated two-year response rate was roughly 77% for G-POEM compared with about 54% for GES. GES appeared to be particularly weak for idiopathic gastroparesis. Adverse events were also more common in the GES group, running about 26% versus roughly 4% for G-POEM.¹⁴ That study was not randomized, so some selection bias could play a role, but the gap is wide enough that many gastroparesis specialists now consider G-POEM the preferred intervention when pyloric dysfunction is present.

The caveat is that G-POEM and GES target different mechanisms. G-POEM addresses pyloric dysfunction, the valve not opening properly. GES targets the neural circuits driving nausea and vomiting. In patients whose main problem is severe nausea without evidence of pyloric tightness, GES may still have a role. This is not an either-or decision so much as a question of matching the procedure to the patient’s physiology.

How Doctors Identify the Right Candidates

The growing use of a tool called EndoFLIP (endoluminal functional lumen imaging probe) has changed how surgeons select patients for pylorus-targeted procedures. During an endoscopy, a small balloon is placed through the pylorus and inflated. The device measures how easily the pylorus stretches open, a property called distensibility. Patients with gastroparesis who have significantly reduced pyloric distensibility compared to healthy controls are considered better candidates for G-POEM or pyloroplasty.¹⁵

EndoFLIP measurements taken after G-POEM also correlate with outcomes. The cross-sectional area of the pylorus after the procedure has been linked to clinical success and improvement in gastric emptying at follow-up.¹⁶ Similarly, patients whose pyloric distensibility improved significantly after G-POEM were much more likely to have a good clinical response at six months.¹⁷

One thing EndoFLIP cannot do is tell the whole story in advance. A common clinical question is whether response to a temporary intervention like botulinum toxin injection or balloon dilation of the pylorus can predict who will do well with a permanent pyloric procedure. The evidence is discouraging: one study found that while about 57% of patients felt better after dilation and about 80% improved after dilation combined with Botox, neither response predicted the final surgical outcome.¹⁸ Doctors sometimes still use Botox as a trial, but these results suggest it should not be treated as a reliable screening test for surgery.

When the First Procedure Fails

No gastroparesis surgery works for everyone, and treatment failure is common enough that a structured salvage pathway exists. After a failed pyloric procedure, management typically starts with confirming the failure through repeat endoscopy and a new gastric emptying study, then optimizing medications and diet. Further workup with EndoFLIP or antroduodenal manometry can help clarify whether the pylorus is still the problem or whether broader stomach dysfunction is responsible.¹⁹

Salvage options depend on what the testing reveals. If the pyloric myotomy looks incomplete, a redo G-POEM may work. If nausea and vomiting remain dominant despite an open pylorus, adding a gastric electrical stimulator can target those specific symptoms. For patients who are severely malnourished and unable to eat, a jejunostomy tube (feeding directly into the small intestine) combined with a venting gastrostomy (a tube that lets gas and fluid drain from the stomach) can stabilize nutrition while buying time. And for the most refractory cases, major anatomic surgery enters the picture.

Gastrectomy and Gastric Bypass as Last Resorts

When less invasive procedures have failed, two radical options remain: removing most of the stomach or bypassing it entirely.

Near-total gastrectomy removes the dysfunctional organ. In a series of 35 patients who had this operation after failing other treatments, nausea improved or resolved in about 69%, chronic abdominal pain in 70%, and bloating in nearly 90%. There were no deaths, but six patients developed leaks requiring reoperation, which is a substantial complication rate for a procedure meant to improve quality of life rather than treat cancer.²⁰ A systematic review found that pyloric surgery and gastrectomy both outperformed gastric electrical stimulation for vomiting specifically.²¹

Roux-en-Y gastric bypass creates a small stomach pouch and reroutes the intestine so food skips most of the stomach. It is best known as a weight-loss surgery, but it can also help gastroparesis by making the stomach’s ability to empty largely irrelevant: the pouch is so small that gravity and intestinal contractions do most of the work. A systematic review found that gastric bypass improved gastric emptying in about 87% of cases, while sleeve gastrectomy improved it in 45% to 67%.²² In a small series of obese patients with diabetic or idiopathic gastroparesis, all who had been on prokinetic medications before gastric bypass were able to stop them afterward.²³

These operations are irreversible and carry significantly higher complication rates than pyloric procedures. They are genuinely last-resort options, reserved for patients whose quality of life has deteriorated to the point where the risks of major surgery are outweighed by the burden of the disease.

Disparities in Access and Outcomes

Gastroparesis surgery outcomes are not evenly distributed. A recent study examining patients who underwent surgery for medically refractory gastroparesis found significant improvements overall, with symptom scores improving and gastric retention at four hours dropping substantially after surgery.²⁴ But the study also flagged that demographic and socioeconomic factors influenced both how patients presented and how they fared afterward. This matches broader patterns in gastroenterology, where access to specialized centers, insurance coverage for newer procedures like G-POEM, and the ability to travel for care all shape who gets treated and when.

G-POEM, in particular, is concentrated at academic medical centers with experienced interventional endoscopists. If you live far from one of these centers, your realistic options may be limited to laparoscopic pyloroplasty or GES, both of which are more widely available. The “best” surgery in a clinical trial is not always the best surgery in your ZIP code.

What Happens to the Gut After Major Surgery

For patients who end up needing gastric bypass, the changes extend beyond the stomach itself. Roux-en-Y gastric bypass substantially reshapes the gut microbiome, the community of bacteria and fungi living in the intestines. Research from a randomized trial found that both gastric bypass and sleeve gastrectomy altered the microbiome in the same general direction, but the changes were larger after gastric bypass. The microbial shifts correlated with improvements in blood sugar control and beta-cell function, and some of these associations persisted even after accounting for weight loss.²⁵ For gastroparesis patients who also have diabetes, this is potentially relevant: the surgery may improve not just stomach emptying but the metabolic dysfunction driving the gastroparesis in the first place.

The microbiome remodeling after gastrointestinal surgery is complex and not always benign. Studies have documented increases in certain bacterial groups that thrive in the altered gut environment and decreases in others associated with gut health.²⁶ The long-term clinical significance of these shifts for gastroparesis patients specifically is still being studied, but it underscores that major anatomic surgery does not just fix one problem in isolation. It changes the entire digestive ecosystem.

Gastroparesis Surgery in Children

Most of the surgical data on gastroparesis comes from adults, and pediatric patients face a narrower set of studied options. A multicenter retrospective study looked at endoscopic balloon dilation and botulinum toxin injection in children with gastroparesis and found both were safe and partially effective in the short term. However, symptoms recurred frequently, and most children needed repeat interventions.²⁷ G-POEM is being performed in adolescents at some centers, but published data on pediatric long-term outcomes remain thin. For families navigating this, the honest answer is that the evidence base lags behind the adult literature by years, and decisions are often extrapolated from adult data with extra caution about growth, nutrition, and the permanence of any surgical alteration.